West Pharmaceutical Services Inc (WST)
321.02
+0.14
(+0.05%)
USD |
NYSE |
Nov 22, 09:30
West Pharmaceutical Services Revenue (Quarterly): 746.90M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 746.90M |
| June 30, 2024 | 702.10M |
| March 31, 2024 | 695.40M |
| December 31, 2023 | 732.00M |
| September 30, 2023 | 747.40M |
| June 30, 2023 | 753.80M |
| March 31, 2023 | 716.60M |
| December 31, 2022 | 708.70M |
| September 30, 2022 | 686.90M |
| June 30, 2022 | 771.30M |
| March 31, 2022 | 720.00M |
| December 31, 2021 | 730.80M |
| September 30, 2021 | 706.50M |
| June 30, 2021 | 723.60M |
| March 31, 2021 | 670.70M |
| December 31, 2020 | 580.20M |
| September 30, 2020 | 548.00M |
| June 30, 2020 | 527.20M |
| March 31, 2020 | 491.50M |
| December 31, 2019 | 470.60M |
| September 30, 2019 | 456.10M |
| June 30, 2019 | 469.70M |
| March 31, 2019 | 443.50M |
| December 31, 2018 | 422.50M |
| September 30, 2018 | 431.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 447.50M |
| March 31, 2018 | 415.70M |
| December 31, 2017 | 415.60M |
| September 30, 2017 | 398.20M |
| June 30, 2017 | 397.60M |
| March 31, 2017 | 387.70M |
| December 31, 2016 | 382.30M |
| September 30, 2016 | 376.70M |
| June 30, 2016 | 388.00M |
| March 31, 2016 | 362.10M |
| December 31, 2015 | 359.70M |
| September 30, 2015 | 344.50M |
| June 30, 2015 | 359.70M |
| March 31, 2015 | 335.90M |
| December 31, 2014 | 349.80M |
| September 30, 2014 | 355.90M |
| June 30, 2014 | 368.90M |
| March 31, 2014 | 346.80M |
| December 31, 2013 | 342.70M |
| September 30, 2013 | 341.80M |
| June 30, 2013 | 344.50M |
| March 31, 2013 | 339.40M |
| December 31, 2012 | 321.50M |
| September 30, 2012 | 303.80M |
| June 30, 2012 | 324.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
470.60M
Minimum
Dec 2019
771.30M
Maximum
Jun 2022
671.51M
Average
707.60M
Median
Revenue (Quarterly) Benchmarks
| Repligen Corp | 154.87M |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.35M |
| Xtant Medical Holdings Inc | 27.94M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 136.00M |
| Total Expenses (Quarterly) | 581.20M |
| EPS Diluted (Quarterly) | 1.85 |
| Enterprise Value | 22.95B |
| Gross Profit Margin (Quarterly) | 35.44% |
| Profit Margin (Quarterly) | 18.21% |
| Earnings Yield | 2.10% |
| Operating Earnings Yield | 2.49% |
| Normalized Earnings Yield | 2.165 |